Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2453
Source ID: NCT00922194
Associated Drug: Extended Release Metformin
Title: Metformin in Overweight Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00922194/results
Conditions: Obesity|Type 2 Diabetes Mellitus
Interventions: DRUG: Extended Release Metformin
Outcome Measures: Primary: Change in Weight From Baseline at 12 Months or More, Change: Weight after 12 months of therapy or more - weight at baseline, Initial and at the end of 12 months or more|Change in Body Mass Index (BMI) From Baseline at 12 Months or More, Change: Body Mass Index (BMI) after 12 months of therapy or more - BMI at baseline, Initial and at the end of 12 months or more|Change in Waist Circumference From Baseline at 12 Months or More, Change: Waist circumference after 12 months or more of therapy - Waist circumference at baseline, Initial and at the end of 12 months or more|Change in Waist Circumference (Cms)/Hip Circumference (Cms)From Baseline at 12 Months or More, Change: Waist circumference/Hip circumference ratio after 12 months or more of therapy - Waist circumference/Hip circumference ratio at baseline, Initial and at the end of 12 months or more|Change in Waist (Cms) /Height (Meters) Ratio From Baseline at 12 Months or More, Change: Waist/Height ratio after 12 months or more of therapy - Waist/Height ratio at baseline, Initial and at the end of 12 months or more|Change in Fasting Blood Glucose From Baseline at 12 Months or More, Change: Fasting blood glucose after 12 months or more of therapy - Fasting blood glucose at baseline, Initial and at the end of 12 months or more|Change in Glycosylated Haemoglobin (A1C) From Baseline at 12 Months or More, Change: Glycosylated Haemoglobin after 12 months or more of therapy - Glycosylated Haemoglobin at baseline., Initial and at the end of 12 months or more |
Sponsor/Collaborators: Sponsor: Era's Lucknow Medical College
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 102
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2006-02
Completion Date: 2008-12
Results First Posted: 2009-06-17
Last Update Posted: 2010-03-23
Locations: Sircar Diabetes Clinic, Lucknow, UP, 226006, India
URL: https://clinicaltrials.gov/show/NCT00922194